{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:10:30Z","timestamp":1791180630284,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4819,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1038\/modpathol.2009.125","type":"journal-article","created":{"date-parts":[[2009,9,4]],"date-time":"2009-09-04T09:59:09Z","timestamp":1252058349000},"page":"1423-1431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression"],"prefix":"10.1016","volume":"22","author":[{"given":"Andrea Proctor","family":"Subhawong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Heaphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kouprina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K","family":"Meeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.125_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","article-title":"ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics","volume":"321","author":"McPherson","year":"2000","journal-title":"BMJ"},{"key":"10.1038\/modpathol.2009.125_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1097-0142(19950101)75:1+<257::AID-CNCR2820751311>3.0.CO;2-Y","article-title":"Breast cancer","volume":"75","author":"Berg","year":"1995","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2009.125_bib3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","article-title":"Gene-expression signatures in breast cancer","volume":"360","author":"Sotiriou","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2009.125_bib4","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"Sotiriou","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.125_bib5","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.125_bib6","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1158\/1078-0432.CCR-08-1208","article-title":"Triple-negative breast cancer: risk factors to potential targets","volume":"14","author":"Schneider","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.125_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2009.125_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1078-0432.217.11.1","article-title":"A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas","volume":"11","author":"Henson","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.125_bib9","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1158\/1078-0432.CCR-05-0684","article-title":"Multiple mechanisms of telomere maintenance exist in liposarcomas","volume":"11","author":"Henson","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.125_bib10","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1158\/0008-5472.CAN-06-0273","article-title":"Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression","volume":"66","author":"Costa","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.125_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(03)12681-5","article-title":"Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme","volume":"361","author":"Hakin-Smith","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2009.125_bib12","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.2007-1840","article-title":"Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma","volume":"93","author":"Else","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/modpathol.2009.125_bib13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm1197-1271","article-title":"Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines","volume":"3","author":"Bryan","year":"1997","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2009.125_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000167814","article-title":"Telomere length maintenance\u2014an ALTernative mechanism","volume":"122","author":"Royle","year":"2008","journal-title":"Cytogenet Genome Res"},{"key":"10.1038\/modpathol.2009.125_bib15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/35036365","article-title":"The function of PML in p53-dependent apoptosis","volume":"2","author":"Guo","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1038\/modpathol.2009.125_bib16","doi-asserted-by":"crossref","first-page":"43491","DOI":"10.1074\/jbc.C100532200","article-title":"PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor Rb","volume":"276","author":"Khan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2009.125_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1349-7006.2008.01063.x","article-title":"Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient gastric carcinoma","volume":"100","author":"Omori","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1038\/modpathol.2009.125_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/path.1191","article-title":"Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTr","volume":"198","author":"Poremba","year":"2002","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2009.125_bib19","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1158\/1078-0432.CCR-07-4082","article-title":"Heterogeneity of breast cancer metastasis: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases","volume":"14","author":"Wu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.125_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9440(10)62553-9","article-title":"Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining","volume":"160","author":"Meeker","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2009.125_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s003359900934","article-title":"Single base discrimination of CENP-B repeats on mouse and human Chromosomes with PNA-FISH","volume":"10","author":"Chen","year":"1999","journal-title":"Mamm Genome"},{"key":"10.1038\/modpathol.2009.125_bib22","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"10.1038\/modpathol.2009.125_bib23","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.125_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0b013e31817f9790","article-title":"Most basal-like breast carcinomas demonstrate the same Rb-\/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically","volume":"33","author":"Subhawong","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.125_bib25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/PAP.0b013e31814b26fe","article-title":"The phenotypic spectrum of basal-like breast cancers: a critical appraisal","volume":"14","author":"Fadare","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2009.125_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PCR.0b013e31812567b4","article-title":"Basal-like breast cancers","volume":"12","author":"Fadare","year":"2007","journal-title":"Pathol Case Rev"},{"key":"10.1038\/modpathol.2009.125_bib27","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/j.1460-2075.1992.tb05245.x","article-title":"Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity","volume":"11","author":"Counter","year":"1992","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.2009.125_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1126\/science.279.5349.349","article-title":"Extension of life-span by introduction of telomerase into normal human cells","volume":"279","author":"Bodnar","year":"1998","journal-title":"Science"},{"key":"10.1038\/modpathol.2009.125_bib29","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1038\/modpathol.2009.125_bib30","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1517\/13543784.10.12.2141","article-title":"Telomerase inhibitors for the treatment of cancer: the current perspective","volume":"10","author":"Perry","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1038\/modpathol.2009.125_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nrc929","article-title":"Telomere maintenance and cancer \u2013 look, no telomerase","volume":"2","author":"Neumann","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2009.125_bib32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.onc.1205058","article-title":"Alternative lengthening of telomeres in mammalian cells","volume":"21","author":"Henson","year":"2002","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2009.125_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2217\/17460751.1.1.125","article-title":"Telomerase promoter reprogramming and interaction with general transcription factors in the human mesenchymal stem cell","volume":"1","author":"Serakinci","year":"2006","journal-title":"Regen Med"},{"key":"10.1038\/modpathol.2009.125_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/82586","article-title":"Telomere maintenance by recombination in human cells","volume":"26","author":"Dunham","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2009.125_bib35","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1158\/0008-5472.CAN-03-4035","article-title":"Alternative lengthening of telomeres is characterized by high rates of telomeric exchange","volume":"64","author":"Londo\u00f1o-Vallejo","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.125_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cell.2004.10.011","article-title":"Homologous recombination generates T-loop-sized deletions at human telomeres","volume":"119","author":"Wang","year":"2004","journal-title":"Cell"},{"key":"10.1038\/modpathol.2009.125_bib37","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1242\/jcs.113.24.4577","article-title":"ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)\/M phase of the cell cycle","volume":"113","author":"Grobelny","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1038\/modpathol.2009.125_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/stem.160413","article-title":"The HER-2\/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy","volume":"16","author":"Ross","year":"1998","journal-title":"Stem Cells"},{"key":"10.1038\/modpathol.2009.125_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1470-2045(09)70063-4","article-title":"Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response","volume":"10","author":"Reinholz","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1038\/modpathol.2009.125_bib40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1072-7515(00)00252-0","article-title":"Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study","volume":"190","author":"Botti","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1038\/modpathol.2009.125_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0046-8177(00)80220-8","article-title":"Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ","volume":"31","author":"Visscher","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2009.125_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ccr.2006.10.009","article-title":"Genomic and transcriptional aberrations linked to breast cancer pathophysiologies","volume":"10","author":"Chin","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1038\/modpathol.2009.125_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2407-8-297","article-title":"Amplification of HER2 is a marker for global genomic instability","volume":"8","author":"Ellsworth","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1038\/modpathol.2009.125_bib44","first-page":"4140","article-title":"Genetic alterations in ERBB2-amplified breast carcinomas","volume":"5","author":"Isola","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.125_bib45","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/sj.onc.1204493","article-title":"Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas","volume":"20","author":"Scheel","year":"2001","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2009.125_bib46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/82586","article-title":"Telomere maintenance by recombination in human cells","volume":"26","author":"Dunham","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2009.125_bib47","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/sj.embor.7400027","article-title":"Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency","volume":"4","author":"Bechter","year":"2003","journal-title":"EMBO Rep"},{"key":"10.1038\/modpathol.2009.125_bib48","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/hmg\/ddi185","article-title":"Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome","volume":"14","author":"Jeyapalan","year":"2005","journal-title":"Hum Mol Genet"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009125","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2009125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:59:54Z","timestamp":1760230794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222024383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0893395222024383"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.125","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}